v3.25.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Conversion of Debt and Interest into Common Stock [Member]
Preferred Stock [Member]
Conversion of Debt and Interest into Common Stock [Member]
Common Stock [Member]
Conversion of Debt and Interest into Common Stock [Member]
Additional Paid-in Capital [Member]
Conversion of Debt and Interest into Common Stock [Member]
Retained Earnings [Member]
Conversion of Debt and Interest into Common Stock [Member]
Parent [Member]
Conversion of Debt and Interest into Common Stock [Member]
Noncontrolling Interest [Member]
Conversion of Debt and Interest into Common Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Sep. 30, 2023 [1]               1,575,502 1          
Balance at Sep. 30, 2023 [1]               $ 1,576 $ 0 $ 2,071,112,998 $ (1,862,162,037) $ 208,952,537 $ 63,855,573 $ 272,808,110
Cashless Warrant exercise (in shares)               0 0          
Cashless Warrant exercise               $ 0 $ 0 67,832,434 0 67,832,434 0 67,832,434
Issuance of common stock for conversion of convertible notes and interest (in shares)               0 0          
Issuance of common stock for conversion of convertible notes and interest               $ 0 $ 0 8,826,351 0 8,826,351 0 8,826,351
Share-based compensation (in shares)               0 0          
Share-based compensation               $ 0 $ 0 35,275,712   35,275,712 0 35,275,712
Preferred stock dividends               0 0 (66,412) 0 (66,412) 0 (66,412)
Changes due to net losses of the subsidiary               0 0 0 0 0 (45,796,565) (45,796,565)
Net Loss               $ 0 $ 0 0 (281,187,675) (281,187,675) 0 (281,187,675)
Common stock issued to settle other derivative liability (in shares)               0 0          
Common stock issued to settle other derivative liability               $ 0 $ 0 3,269,180 0 3,269,180 0 3,269,180
Common stock issued to settle legal commitment (in shares)               0 0          
Common stock issued to settle legal commitment               $ 0 $ 0 639,256 0 639,256 0 639,256
Extinguishment of Series C P/S by issuance of Series E P/S (in shares)               (1,211,299) 0          
Extinguishment of Series C P/S by issuance of Series E P/S               $ (1,212) $ 0 0 0 (1,212) 0 (1,212)
Financial result from exchange of Series C P/S for Series E P/S               $ 0 $ 0 (8,604,029) 0 (8,604,029) 0 (8,604,029)
Balance (in shares) at Jun. 30, 2024               364,203 1          
Balance at Jun. 30, 2024               $ 364 $ 0 2,178,285,490 (2,143,349,712) 34,936,142 18,059,008 52,995,150
Balance (in shares) at Mar. 31, 2024               1,575,502 1          
Balance at Mar. 31, 2024               $ 1,576 $ 0 2,151,075,158 (2,055,988,895) 95,087,839 22,326,804 117,414,643
Cashless Warrant exercise (in shares)               0 0          
Cashless Warrant exercise               $ 0 $ 0 8,667,399 0 8,667,399 0 8,667,399
Issuance of common stock for conversion of convertible notes and interest (in shares)               0 0          
Issuance of common stock for conversion of convertible notes and interest               $ 0 $ 0 8,826,351 0 8,826,351 0 8,826,351
Share-based compensation               0 0 14,435,242 0 14,435,242 0 14,435,242
Preferred stock dividends               0 0 (23,067) 0 (23,067) 0 (23,067)
Changes due to net losses of the subsidiary               0 0 0 0 0 (4,267,796) (4,267,796)
Net Loss               $ 0 $ 0 0 (87,360,817) (87,360,817) 0 (87,360,817)
Common stock issued to settle other derivative liability (in shares)               0 0          
Common stock issued to settle other derivative liability               $ 0 $ 0 3,269,180 0 3,269,180 0 3,269,180
Common stock issued to settle legal commitment (in shares)               0 0          
Common stock issued to settle legal commitment               $ 0 $ 0 639,256 0 639,256 0 639,256
Extinguishment of Series C P/S by issuance of Series E P/S (in shares)               (1,211,299) 0          
Extinguishment of Series C P/S by issuance of Series E P/S               $ (1,212) $ 0 0 0 (1,212) 0 (1,212)
Financial result from exchange of Series C P/S for Series E P/S               $ 0 $ 0 (8,604,029) 0 (8,604,029) 0 (8,604,029)
Balance (in shares) at Jun. 30, 2024               364,203 1          
Balance at Jun. 30, 2024               $ 364 $ 0 2,178,285,490 (2,143,349,712) 34,936,142 18,059,008 52,995,150
Balance (in shares) at Sep. 30, 2024 [1]               364,203 1          
Balance at Sep. 30, 2024 [1]               $ 364 $ 0 2,290,664,548 (2,319,220,938) (28,556,026) 12,010,149 (16,545,877)
Cashless Warrant exercise (in shares)               0 80,911          
Cashless Warrant exercise               $ 0 $ 81 112,386,508 0 112,386,589 0 112,386,589
Issuance of common stock for conversion of convertible notes and interest (in shares) 0 2,561                        
Issuance of common stock for conversion of convertible notes and interest $ 0 $ 3 $ 27,579,422 $ 0 $ 27,579,425 $ 0 $ 27,579,425              
Common stock issued to settle matured loans and advances (in shares)               0 0          
Common stock issued to settle matured loans and advances               $ 0 $ 0 3,000,001 0 3,000,001 0 3,000,001
Common stock issued under equity line of credit (in shares)               0 0          
Common stock issued under equity line of credit               $ 0 $ 0 1,017,135 0 1,017,135 0 1,017,135
Share-based compensation (in shares)               0 16,089          
Share-based compensation               $ 0 $ 16 70,032,574   70,032,590 0 70,032,590
Preferred stock dividends               $ 0 $ 0 (76,823) 0 (76,823) 0 (76,823)
Common stock issued to avoid fractional shares on reverse stock split (in shares)               0 6          
Noncontrolling interest - change from additional investments into subsidiary               $ 0 $ 0 (1,598,668) 0 (1,598,668) 1,598,668 0
Changes due to net losses of the subsidiary               0 0 0 0 0 (12,757,919) (12,757,919)
Net Loss               $ 0 $ 0 0 (291,689,264) (291,689,264) 0 (291,689,264)
Balance (in shares) at Jun. 30, 2025               364,203 99,568          
Balance at Jun. 30, 2025               $ 364 $ 100 2,503,004,697 (2,610,910,202) (107,905,041) 850,898 (107,054,143)
Balance (in shares) at Mar. 31, 2025               364,203 41          
Balance at Mar. 31, 2025               $ 364 $ 0 2,408,230,419 (2,481,185,386) (72,954,603) 3,414,074 (69,540,529)
Cashless Warrant exercise (in shares)               0 80,876          
Cashless Warrant exercise               $ 0 $ 81 66,396,437 0 66,396,518 0 66,396,518
Issuance of common stock for conversion of convertible notes and interest (in shares)               0 2,561          
Issuance of common stock for conversion of convertible notes and interest               $ 0 $ 3 1,287,999 0 1,288,002 0 1,288,002
Share-based compensation (in shares)               0 16,084          
Share-based compensation               $ 0 $ 16 26,597,059 0 26,597,075 0 26,597,075
Preferred stock dividends               $ 0 $ 0 (26,785) 0 (26,785) 0 (26,785)
Common stock issued to avoid fractional shares on reverse stock split (in shares)               0 6          
Noncontrolling interest - change from additional investments into subsidiary               $ 0 $ 0 519,568 0 519,568 (519,568) 0
Changes due to net losses of the subsidiary               0 0 0 0 0 (2,043,608) (2,043,608)
Net Loss               $ 0 $ 0 0 (129,724,816) (129,724,816) 0 (129,724,816)
Balance (in shares) at Jun. 30, 2025               364,203 99,568          
Balance at Jun. 30, 2025               $ 364 $ 100 $ 2,503,004,697 $ (2,610,910,202) $ (107,905,041) $ 850,898 $ (107,054,143)
[1] Adjusted retroactively for reverse stock splits, see Note 1 - Description of Business and Basis of Presentation